|Bid||0.00 x 900|
|Ask||0.00 x 1200|
|Day's range||23.74 - 24.83|
|52-week range||12.63 - 26.60|
|Beta (5Y monthly)||1.47|
|PE ratio (TTM)||N/A|
|Earnings date||28 Apr 2021 - 03 May 2021|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||09 Dec 2015|
|1y target est||30.92|
Joining me today from CryoLife management team are Pat Mackin, CEO; and Ashley Lee, CFO. Comments made on this call that look forward in time involve risks and uncertainties and are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The forward-looking statements include statements made as to the Company's or management's intentions, hopes, beliefs, expectations or predictions of the future.
CryoLife (CRY) delivered earnings and revenue surprises of 1100.00% and 4.46%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Fourth Quarter and Recent Business Highlights: